{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:50:38Z","timestamp":1782496238734,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA26694"],"award-info":[{"award-number":["R01CA26694"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007259","name":"Stony Brook University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-1031"],"award-info":[{"award-number":["W81XWH-22-1-1031"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tranon.2026.102819","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:57:35Z","timestamp":1779001055000},"page":"102819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association"],"prefix":"10.1016","volume":"69","author":[{"given":"Ahmed M.","family":"Elgehama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaceline Gislaine","family":"Pires Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaoke","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6314-2370","authenticated-orcid":false,"given":"Lauryn","family":"Ruegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-1783","authenticated-orcid":false,"given":"Sungyong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-3570","authenticated-orcid":false,"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102819_bib0001","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acs.jmedchem.3c00593","article-title":"Receptor interacting Ser\/Thr-protein kinase 2 as a new therapeutic target","volume":"66","author":"Rivoal","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tranon.2026.102819_bib0002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41467-022-28340-6","article-title":"Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis","volume":"13","author":"Yan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102819_bib0003","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12920-022-01239-3","article-title":"A Pancancer analysis of the carcinogenic role of receptor-interacting serine\/threonine protein kinase-2 (RIPK2) in human Tumours","volume":"15","author":"Zhang","year":"2022","journal-title":"BMC. Med. Genomics."},{"key":"10.1016\/j.tranon.2026.102819_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115683","article-title":"RIPK2 inhibitors for disease therapy: current status and perspectives","volume":"259","author":"Tian","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tranon.2026.102819_bib0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102819_bib0006","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102819_bib0007","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2026.102819_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.tranon.2026.102819_bib0009","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC. Bioinform."},{"key":"10.1016\/j.tranon.2026.102819_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.tranon.2026.102819_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat. Soc. Ser. B Stat. Methodol."},{"key":"10.1016\/j.tranon.2026.102819_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.101163","article-title":"Extraction of high-quality RNA from mouse pancreatic tumors","volume":"7","author":"Chougoni","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.tranon.2026.102819_bib0013","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tranon.2026.102819_bib0014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102819_bib0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102819_bib0016","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/acsmedchemlett.7b00258","article-title":"Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases","volume":"8","author":"He","year":"2017","journal-title":"ACS. Med. Chem. Lett."},{"key":"10.1016\/j.tranon.2026.102819_bib0017","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41586-025-09763-9","article-title":"Inhibitors supercharge kinase turnover through native proteolytic circuits","volume":"649","author":"Scholes","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102819_bib0018","doi-asserted-by":"crossref","first-page":"D183","DOI":"10.1093\/nar\/gkad1016","article-title":"KnockTF 2.0: a comprehensive gene expression profile database with knockdown\/knockout of transcription (co-)factors in Multiple species","volume":"52","author":"Feng","year":"2024","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102819_bib0019","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/2643-3230.BCD-20-0108","article-title":"Lysine demethylase 5A is required for MYC-driven transcription in multiple myeloma","volume":"2","author":"Ohguchi","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.tranon.2026.102819_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-021-01041-1","article-title":"The emerging role of KDM5A in human cancer","volume":"14","author":"Yang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2026.102819_bib0021","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12967-023-04633-2","article-title":"Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer","volume":"21","author":"Zhu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tranon.2026.102819_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138402","article-title":"Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer","volume":"286","author":"Zhu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tranon.2026.102819_bib0023","article-title":"Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer","author":"Xiong","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.tranon.2026.102819_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3892\/or.2017.5669","article-title":"Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer","volume":"38","author":"Hata","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2026.102819_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41419-023-05614-5","article-title":"SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4","volume":"14","author":"Cheng","year":"2023","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.102819_bib0026","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/onc.2013.176","article-title":"Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2","volume":"33","author":"Tian","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.102819_bib0027","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/physrev.00016.2015","article-title":"TRPV4: molecular conductor of a diverse orchestra","volume":"96","author":"White","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tranon.2026.102819_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117233","article-title":"LAMB3: central role and clinical significance in neoplastic and non-neoplastic diseases","volume":"178","author":"Yu","year":"2024","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.tranon.2026.102819_bib0029","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41467-023-36486-0","article-title":"SVEP1 is an endogenous ligand for the orphan receptor PEAR1","volume":"14","author":"Elenbaas","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102819_bib0030","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acs.jmedchem.3c00593","article-title":"Receptor interacting ser\/thr-protein kinase 2 as a new therapeutic target","volume":"66","author":"Rivoal","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tranon.2026.102819_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of Human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:15:33Z","timestamp":1782494133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S1936523326001567"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102819","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102819"}}